Clinical Trial Update: Rare CNS Tumors Outcomes &Risk

View source ↗

Summary

A National Cancer Institute clinical trial update reports outcomes and risks for rare central nervous system tumors, including meningioma, ependymoma, medullobl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cns Sarcoma
• Ependymoma
• Medulloblastoma
• Meningioma
• Primitive Neuroectodermal Tumor

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: High Grade Meningioma, Ependymoma | Status: COMPLETED